Islamoğlu, F. 2024. Molecular docking, bioactivity, adme, toxicity risks, and quantum mechanical parameters of some 1,2-dihydroquinoline derivatives were calculated theoretically for investigation of its use as a pharmaceutical active ingredient in the treatment of multiple sclerosis (MS). Prospects in Pharmaceutical Sciences. 22, 4 (Dec. 2024), 168–187. DOI:https://doi.org/10.56782/pps.261.